Herpevax

Herpes Simplex Virus Vaccine

RIC Monomer

Complex Formation

Full Protection in 1-2 Doses

Multiple Antigen Display

No Adjuvant Required

Easy to Modify

Protection Against HSV-1 and HSV-2

HerpeVax used VaxSyna's vaccine platform to target HSV antigen(s) to enhance antigen presentation. Preliminary data indicate that the vaccine platform induces a neutralizing antibody response against both HSV-1 and HSV-2 and a 100-fold increase in antigen-specific titers after a single vaccine dose

Diamos, A. G. et al. A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice. Front. Immunol. 14, 1085911 (2023).